


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.17%
+0.88%
PFE
Pfizer
$26.92

Login to see Pfizer (PFE) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Investors confidence is positive

Trading below its fair value

Outperform the market
Risk Analysis

High risk of cutting its dividend
PFE Price Performance
$26.58 (+1.28%)
$25.58 (+5.24%)
$25.06 (+7.42%)
$22.92 (+17.45%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
High risk of cutting its dividend
Future
Future
Trading below its fair value
Outperform the market
PFE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PFE Street Sentiment is bullish but have mixed views on the near-term outlook
PFE has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 03, 2026
Reiterate
Neutral
Goldman Sachs
Jan 16, 2026
Initiate
Neutral
UBS
Jan 12, 2026
Initiate
Neutral
UBS
Dec 30, 2025
Reiterate
Buy
Scotiabank
Dec 22, 2025
Downgrade
Hold
NVO
Novo Nordisk A/S
37.52
+0.21%
NVS
Novartis AG
154.05
-0.66%
AZN
Astrazeneca
204.03
-0.40%
ABBV
AbbVie
207.94
-2.10%
SNY
Sanofi
46.76
-0.68%
What is PFE current stock price?
What are PFE stock strengths?
What is PFE Risk Level?
What is PFE market cap and volume?
What is PFE current Stock IQ?
Should I buy PFE stock right now?
Is PFE a Strong Buy right now?
What does a 'Strong Buy' rating mean for PFE?
What does a 'Strong Sell' rating mean for PFE?
What factors influence PFE's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
PFE
Pfizer
Current Price
$26.92
Runners Also Watch
NVO
Novo Nordisk A/S
37.52
+0.21%
NVS
Novartis AG
154.05
-0.66%
AZN
Astrazeneca
204.03
-0.40%
ABBV
AbbVie
207.94
-2.10%
SNY
Sanofi
46.76
-0.68%

PFE Price Performance
$26.58 (+1.28%)
$25.58 (+5.24%)
$25.06 (+7.42%)
$22.92 (+17.45%)
PFE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
High risk of cutting its dividend
Future
Future
Trading below its fair value
Outperform the market
PFE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PFE Street Sentiment is bullish but have mixed views on the near-term outlook
PFE has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
PFE Stock IQ
Stock Insights
Strengths

Investors confidence is positive

Trading below its fair value

Outperform the market
Risk Analysis

High risk of cutting its dividend
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.